Home Cart Sign in  
Chemical Structure| 1508-65-2 Chemical Structure| 1508-65-2

Structure of Oxybutynin chloride
CAS No.: 1508-65-2

Chemical Structure| 1508-65-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Oxybutynin HCl a synthetic anticholinergic agent used for treatment of urinary incontinence and overactive bladder syndrome, with elimination half-life of ‎12.4–13.2 hours. Oxybutynin HCl is the HCl form of Oxybutynin.

Synonyms: Oxybutynin hydrochloride; Oxybutynin (hydrochloride); MJ4309-1

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Oxybutynin chloride

CAS No. :1508-65-2
Formula : C22H32ClNO3
M.W : 393.95
SMILES Code : O=C(C(O)(C1=CC=CC=C1)C2CCCCC2)OCC#CCN(CC)CC.[H]Cl
Synonyms :
Oxybutynin hydrochloride; Oxybutynin (hydrochloride); MJ4309-1
MDL No. :MFCD00072150
InChI Key :SWIJYDAEGSIQPZ-UHFFFAOYSA-N
Pubchem ID :91505

Safety of Oxybutynin chloride

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • mAChR

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02386072 - Completed - -
NCT00547378 Urinary Incontinence, Urgency-... More >>frequency Overactive Bladder Less << Phase 4 Completed - -
NCT00366002 Overactive Bladder (OAB) Phase 4 Completed - -
NCT00547378 - Completed - -
NCT02865395 Overactive Bladder Phase 4 Terminated(Another study publi... More >>shed with similar results) Less << - United States, District of Col... More >>umbia George Washington University Washington, District of Columbia, United States, 20037 Less <<
NCT01829425 Urinary Incontinence, Urge Not Applicable Completed - United States, New Mexico ... More >> University of New Mexico Health Science Center Albuquerque, New Mexico, United States, 87131 Less <<
NCT03602508 - Active, not recruiting February 2019 Australia ... More >> Site AU10000 Sydney, Australia Korea, Republic of Site KR82001 Seoul, Korea, Republic of Less <<
NCT01557244 Urinary Bladder, Neurogenic Phase 3 Recruiting November 13, 2019 -
NCT01148186 Polypharmacy ... More >>Incontinence Insomnia Anxiety Less << Phase 4 Terminated(Study funding perio... More >>d reached conclusion. Sample size sufficient to complete the analysis on benzodiazepines.) Less << - Canada, Quebec ... More >> Le Groupe Jean Coutu Inc. Longueuil, Quebec, Canada, J4G 1S8 Less <<
NCT03572231 - Recruiting December 2019 Korea, Republic of ... More >> Site KR410008 Recruiting Daejeon, Korea, Republic of Site KR410009 Recruiting Incheon, Korea, Republic of Site KR410001 Recruiting Seoul, Korea, Republic of Site KR410003 Recruiting Seoul, Korea, Republic of Site KR410006 Recruiting Seoul, Korea, Republic of Taiwan Site TW158001 Recruiting Hualien City, Taiwan Less <<
NCT00175123 Myelomeningocele ... More >> Bladder, Neurogenic Less << Phase 4 Unknown June 2008 Denmark ... More >> Department of Urology, Aarhus University Hospital, Section Skejby Aarhus, Aarhus N, Denmark, 8200 Less <<
NCT01187498 Overactive Bladder Phase 3 Completed - United States, Alabama ... More >> Birmingham VA Medical Center Birmingham, Alabama, United States, 35233 United States, Georgia Atlanta VA Medical and Rehab Center, Decatur Decatur, Georgia, United States, 30033 Less <<
NCT00411437 Memory Cognit... More >>ion Less << Phase 4 Completed - United States, Arizona ... More >> Pfizer Investigational Site Tucson, Arizona, United States, 85741 United States, Florida Pfizer Investigational Site Brooksville, Florida, United States, 34613 Pfizer Investigational Site DeLand, Florida, United States, 32720 Pfizer Investigational Site Naples, Florida, United States, 34102 Pfizer Investigational Site Ocala, Florida, United States, 34471 Pfizer Investigational Site Ocala, Florida, United States, 34474 Pfizer Investigational Site St. Petersburg, Florida, United States, 33709 Pfizer Investigational Site Tampa, Florida, United States, 33606 Pfizer Investigational Site West Palm Beach, Florida, United States, 33407 Less <<
NCT01187498 - Completed - -
NCT01450332 Anterior Cruciate Ligament Rup... More >>ture Less << Not Applicable Unknown January 2013 Israel ... More >> Shhare Zedek Medical Center Recruiting Jerusalem, Israel, 91031 Principal Investigator: Yoram Litwin, MD Less <<
NCT00892450 Parkinson's Disease ... More >> Overactive Bladder Less << Not Applicable Completed - United States, Pennsylvania ... More >> VA Medical Center, Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01370811 Sialorrhoea Phase 2 Completed - United States, Michigan ... More >> QUEST Research Institute Bingham Farms, Michigan, United States, 48025 Less <<
NCT00223821 Urinary Incontinence Not Applicable Completed - United States, Alabama ... More >> Birmingham VA Medical Center Birmingham, Alabama, United States, 35233 Less <<
NCT00800462 Spinal Cord Injury ... More >> Neurogenic Detrusor Overactivity Less << Phase 4 Completed - Canada, Manitoba ... More >> University of Manitoba, Health Sciences Centre Winnipeg, Manitoba, Canada, R3A1R9 Canada, Ontario Toronto Rehabilitation Institute, Lyndhurst Centre Toronto, Ontario, Canada, M4G 3V9 Less <<
NCT00223821 - Completed - -
NCT01824420 Overactive Bladder Phase 4 Completed - Taiwan ... More >> Buddhist Tzu Chi General Hospital Hualien, Taiwan, 970 Less <<
NCT01899794 Urinary Incontinence Mixed (St... More >>ress and Urge) Less << Phase 4 Completed - -
NCT00629642 Multiple Sclerosis ... More >> Neurogenic Bladder Spinal Cord Diseases Less << Phase 4 Completed - -
NCT01126424 Cognition Phase 4 Completed - United Kingdom ... More >> Blackpool, Lancashire, United Kingdom, FY2 0JH Manchester, Lancashire, United Kingdom, M50 2GY Bradford, Yorkshire, United Kingdom, BD3 0DQ Less <<
NCT02704013 Overactive Bladder Not Applicable Unknown December 2017 Croatia ... More >> Children's Hospital Zagreb Zagreb, Croatia, 10000 Less <<
NCT01126424 - Completed - -
NCT01178827 Overactive Bladder Phase 4 Completed - United States, Utah ... More >> Salt Lake City, Utah, United States Less <<
NCT00501267 Overactive Bladder Phase 1 Completed - United States, Washington ... More >> GSK Investigational Site Tacoma, Washington, United States, 98418 Less <<
NCT01178827 - Completed - -
NCT02070042 Overactive Bladder Not Applicable Terminated(Lack of participati... More >>on) Less << - United States, Ohio ... More >> Good Samaritan Hospital Cincinnati, Ohio, United States, 45220 Less <<
NCT00293839 Urinary Incontinence Phase 3 Completed - -
NCT02176642 - Terminated - -
NCT00269750 Urge Incontinence Phase 3 Completed - -
NCT00338624 Urination Disorders Phase 3 Completed - -
NCT01716624 Neurogenic Bladder Phase 3 Completed - Canada, Ontario ... More >> London Health Sciences Centre - Victoria Hospital London, Ontario, Canada, N6A 5W9 Less <<
NCT00350636 Overactive Bladder Phase 3 Completed - -
NCT00304499 Urinary Incontinence Phase 3 Completed - -
NCT03050827 Diabetic; Neuropathic, Polyneu... More >>ropathy (Manifestation) Less << Phase 3 Completed - United States, Virginia ... More >> Eastern Virgnia Medical School, Strelitz Diabetes Center Norfolk, Virginia, United States, 23510f Less <<
NCT00649272 Healthy Phase 1 Completed - United States, North Dakota ... More >> PRACS Institute Ltd. - Cetero Research Fargo, North Dakota, United States, 58104 Less <<
NCT00749632 Urinary Incontinence, Urge Phase 2 Completed - United States, Maryland ... More >> SNBL Clinical Pharmacology Center Baltimore, Maryland, United States, 21201 United States, New Jersey Advanced Biomedical Research Hackensack, New Jersey, United States, 07601 Less <<
NCT00224146 Overactive Bladder ... More >> Urinary Incontinence Quality of Life Less << Phase 4 Completed - United States, Alabama ... More >> Mobile, Alabama, United States United States, Arizona Tucson, Arizona, United States United States, California Torrance, California, United States United States, Connecticut Rocky Hill, Connecticut, United States United States, Georgia Valdosta, Georgia, United States United States, Louisiana Gretna, Louisiana, United States United States, Michigan Bloomfield Hills, Michigan, United States United States, New York Poughkeepsie, New York, United States United States, North Carolina Winston-Salem, North Carolina, United States United States, Texas Tomball, Texas, United States Less <<
NCT02176642 Urinary Urge Incontinence Phase 4 Terminated - United States, North Carolina ... More >> Duke Urogynecology Durham, North Carolina, United States, 27707 Duke OB/GYN Consultants of Raleigh Raleigh, North Carolina, United States, 27607 Less <<
NCT00650481 Healthy Phase 1 Completed - United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 Less <<
NCT00350636 - Completed - -
NCT00649727 Healthy Phase 1 Completed - United States, West Virginia ... More >> Kendle International Inc. Morgantown, West Virginia, United States, 26505 Less <<
NCT00649129 Healthy Phase 1 Completed - United States, West Virginia ... More >> Kendle International Inc. Morgantown, West Virginia, United States, 26505 Less <<
NCT00648843 Healthy Phase 1 Completed - United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 Less <<
NCT00926926 Healthy Phase 1 Completed - United States, Missouri ... More >> St. Charles, Missouri, United States Less <<
NCT00649259 Healthy Phase 1 Completed - United States, West Virginia ... More >> Kendle International Inc. Morgantown, West Virginia, United States, 26505 Less <<
NCT00990886 Menopause Hot... More >> Flashes Less << Phase 2 Completed - -
NCT02240459 Overactive Bladder ... More >> Mild Cognitive Impairment Less << Phase 2 Recruiting December 2019 Canada, Alberta ... More >> Division of Geriatric Medicine, Clinical Sciences Building, University of Alberta Hosp Recruiting Edmonton, Alberta, Canada, T6G 2P4 Contact: Adrian Wagg, MD    780 492 5338    adrian.wagg@ualberta.ca    Contact: Saima Rajabali, MBBS    780 492 3700    srajabal@ualberta.ca    Principal Investigator: Adrian S Wagg, MD          Sub-Investigator: Saima Rajabali, MBBS          Sub-Investigator: William Gibson, MBBS Less <<
NCT02522936 Overactive Bladder ... More >> Xerostomia Compliance Less << Phase 4 Withdrawn(Due to lack of fundi... More >>ng and necessary personnel we determined that the study could not be done.) Less << December 30, 2019 -
NCT00269724 Urinary Incontinence Phase 3 Completed - -
NCT00170768 Healthy Volunteers Phase 2 Completed - United States, District of Col... More >>umbia Washington Neuropsychological Institute LLC Georgetown Washington, District of Columbia, United States, 20016 Less <<
NCT00431041 Overactive Bladder Phase 4 Completed - Canada, Alberta ... More >> Calgary, Alberta, Canada, T2V 4R6 Edmonton, Alberta, Canada, T5H 3V9 Canada, British Columbia Vancouver, British Columbia, Canada, V6T 2B5 Victoria, British Columbia, Canada, V8T 5G1 Canada, Nova Scotia Halifax, Nova Scotia, Canada, B3H 3A7 Canada, Ontario Guelph, Ontario, Canada, N1H 5J1 Kitchener, Ontario, Canada, N2N 2B9 Toronto, Ontario, Canada, M4N 3M5 Toronto, Ontario, Canada, M5G 1Z5 Toronto, Ontario, Canada, M5T 2S8 Toronto, Ontario, Canada, M6A 3B5 Canada, Quebec Montreal, Quebec, Canada, H3T 1E2 Less <<
NCT00752141 Healthy Volunteers Phase 1 Completed - United States, Arizona ... More >> Tucson, Arizona, United States, 85741-3656 United States, California National City, California, United States, 91950 United States, Florida Maitland, Florida, United States, 32751 Naples, Florida, United States, 34102 Ocala, Florida, United States, 34471 United States, Georgia Atlanta, Georgia, United States, 30341-4155 Less <<
NCT01956591 - Completed - Brazil ... More >> Hospital Israelita Albert Einstein São Paulo, Brazil, 05652000 Less <<
NCT00816972 Post-nasal Drip ... More >> Seasonal Allergic Rhinitis Rhinorrhea Less << Phase 2 Completed - -
NCT03205605 Heat Effect Early Phase 1 Recruiting February 28, 2019 United States, Maryland ... More >> General Clinical Research Center (GCRC) at the University of Maryland Medical Center Recruiting Baltimore, Maryland, United States, 21201 Less <<
NCT00431041 - Completed - -
NCT01796548 - Terminated(Slow rate of partic... More >>ipant's enrollment) Less << - -
NCT02973659 Hyperhidrosis Not Applicable Completed - -
NCT01477736 Spinal Cord Injury Not Applicable Completed - Brazil ... More >> UNICAMP, Division of Urology Campinas, Sao Paulo, Brazil, 13083887 Less <<
NCT00224016 Detrusor Hyperreflexia Phase 4 Completed - -
NCT01796548 Detrusor Function, Overactive Phase 4 Terminated(Slow rate of partic... More >>ipant's enrollment) Less << - Thailand ... More >> Bangkok, Thailand Chiangmai, Thailand Phathumwan, Thailand Less <<
NCT00224016 - Completed - -
NCT02961790 Breast Carcinoma ... More >> Ductal Breast Carcinoma In Situ Hot Flashes Lobular Breast Carcinoma In Situ No Evidence of Disease Less << Phase 3 Active, not recruiting May 1, 2019 United States, Illinois ... More >> Illinois CancerCare-Peoria Peoria, Illinois, United States, 61615 Carle Cancer Center NCI Community Oncology Research Program Urbana, Illinois, United States, 61801 United States, Iowa Oncology Associates at Mercy Medical Center Cedar Rapids, Iowa, United States, 52403 United States, Kansas Cancer Center of Kansas - Wichita Wichita, Kansas, United States, 67214 United States, Kentucky Saint Elizabeth Medical Center South Edgewood, Kentucky, United States, 41017 United States, Michigan Michigan Cancer Research Consortium NCORP Ann Arbor, Michigan, United States, 48106 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina Waverly Hematology Oncology Cary, North Carolina, United States, 27518 United States, South Carolina AnMed Health Cancer Center Anderson, South Carolina, United States, 29621 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57701 United States, Wisconsin Saint Vincent Hospital -Green Bay Green Bay, Wisconsin, United States, 54301 University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Marshfield Clinic Marshfield, Wisconsin, United States, 54449 Less <<
NCT01423838 Overactive Bladder Phase 4 Unknown September 2012 Turkey ... More >> Turkish Republic Ministry of Health Adana Numune Training and Research Hospital Not yet recruiting Adana, Turkey, 01150 Contact: Murat Api, M.D., Ph.D.    +905424241807    muratapi@hotmail.com    Contact: Hakan Aytan, M.D.    +905056833866    drhakanaytan@yahoo.com Less <<
NCT00613327 Urinary Bladder, Overactive Phase 4 Completed - -
NCT00224029 - Completed - -
NCT02483793 Disorder of Urinary Stent Not Applicable Unknown December 2016 -
NCT00909181 Urge Urinary Incontinence ... More >> Urinary Frequency Less << Phase 3 Completed - -
NCT00224029 Detrusor Hyperreflexia Phase 4 Completed - United States, Georgia ... More >> Atlanta, Georgia, United States United States, New York Bronx, New York, United States United States, North Carolina Chapel Hill, North Carolina, United States Charlotte, North Carolina, United States United States, Texas Dallas, Texas, United States Houston, Texas, United States Less <<
NCT01050114 Overactive Bladder Phase 3 Unknown July 2018 United States, Texas ... More >> Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Contact: Sebrina Tello    713-798-8106    stello@bcm.edu    TIRR-Memorial Hermann Not yet recruiting Houston, Texas, United States, 77030 Contact: Sebrina Tello    713-798-8106    stello@bcm.edu    Sub-Investigator: John E. Bertini, Jr., MD Less <<
NCT00613327 - Completed - -
NCT01192568 Overactive Detrusor ... More >> Neurogenic Bladder Less << Phase 4 Recruiting June 12, 2020 United States, California ... More >> Loma Linda University Health Recruiting Loma Linda, California, United States, 92354 Atlantic Urology Medical Group Terminated Long Beach, California, United States, 90806 Cedars-Sinai Medical Center Recruiting Los Angeles, California, United States, 90048 Children's Hospital of Orange County Recruiting Orange, California, United States, 92868 United States, Colorado Urology Associates Recruiting Englewood, Colorado, United States, 80113 United States, Georgia Augusta University Recruiting Augusta, Georgia, United States, 30912 United States, Michigan Children's Hospital of Michigan Terminated Detroit, Michigan, United States, 48201 United States, Mississippi University of Mississippi Medical Center Recruiting Jackson, Mississippi, United States, 39216 United States, New York Albany Medical College Not yet recruiting Albany, New York, United States, 12208 United States, North Carolina Carolinas Medical Center Recruiting Charlotte, North Carolina, United States, 28207 Associated Urologists of North Carolina Recruiting Raleigh, North Carolina, United States, 27612 United States, Ohio Children's Hospital Medical Center of Akron Terminated Akron, Ohio, United States, 44308 United States, Oregon Oregon Health and Science University Not yet recruiting Portland, Oregon, United States, 97239 United States, Texas Texas Children's Hospital - BCM Not yet recruiting Houston, Texas, United States, 77030 United States, Virginia Children's Hospital of the King's Daughters Recruiting Norfolk, Virginia, United States, 23507 Puerto Rico Centro de Investigaciones Clinicas, San Jorge Children's Hospital Recruiting San Juan, Puerto Rico, 00912 Less <<
NCT01118429 Axillary Hyperhidrosis ... More >> Osmidrosis Less << Not Applicable Completed - Brazil ... More >> Hospital das Clinicas da FMUSP Sao Paulo, Brazil, 04534000 Less <<
NCT02327936 Overactive Bladder Phase 3 Completed - -
NCT02908529 Obstructive Sleep Apnea (OSA) Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Sleep Disorders Research Program Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00909181 - Completed - -
NCT02633371 - Completed - -
NCT02633371 Hyperhidrosis Not Applicable Completed - United States, Colorado ... More >> Children's Hospital, Colorado Aurora, Colorado, United States, 80045 Less <<
NCT03187795 Spinal Cord Injuries ... More >> Urinary Bladder, Neurogenic Less << Phase 2 Not yet recruiting March 30, 2022 United States, New Jersey ... More >> Kessler Institute for Rehabilitation Not yet recruiting West Orange, New Jersey, United States, 07052 Contact: Todd A. Linsenmeyer, M.D.    973-243-6924    tlinsenmeyer@kessler-rehab.com    Contact: Trevor A. Dyson-Hudson, M.D.    973-324-3576    tdysonhudson@kesslerfoundation.org    Principal Investigator: Todd A. Linsenmeyer, M.D.          Principal Investigator: Steven C. Kirshblum, M.D.          Principal Investigator: Trevor A. Dyson-Hudson, M.D. Less <<
NCT02099695 Hyperhidrosis Phase 3 Withdrawn(The company changed ... More >>the strategy.) Less << February 2016 Brazil ... More >> Hospital Israelita Albert Einstein São Paulo, Brazil, 05652-90 Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo São Paulo, Brazil Less <<
NCT01328015 Hyperhidrosis Phase 2 Completed - -
NCT02538302 Nocturnal Enuresis Phase 3 Completed - Iran, Islamic Republic of ... More >> Shahid Mohammadi hospital Bandar Abbas, Hormozgan, Iran, Islamic Republic of, 79176 Less <<
NCT01855256 Hyperhidrosis Phase 3 Completed - France ... More >> Hospital, Brest Brest, France, 29609 CHG Landerneau Landerneau, France, 29800 CHG de Morlaix Morlaix, France, 29600 Dermatologist'S Office Quimper, France, 29000 Less <<
NCT01310712 Hyperhidrosis Phase 4 Completed - Brazil ... More >> Hospital das Clinicas da FMUSP Sao Paulo, Brazil, 05679040 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.54mL

0.51mL

0.25mL

12.69mL

2.54mL

1.27mL

25.38mL

5.08mL

2.54mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories